B |
2019-02-01 14:23:06.0 |
Millendo Therapeutics |
OVAS |
New Enterprise Associates 15 |
2.59% |
view |
B |
2017-03-31 16:45:29.0 |
OvaScience |
OVAS |
ORBIS INVESTMENT MANAGEMENT LTD |
100.0% |
view |
S |
2017-02-14 11:45:02.0 |
OvaScience |
OVAS |
Arrowpoint Asset Management |
0.0% |
view |
B |
2017-02-09 13:44:35.0 |
OvaScience |
OVAS |
ADAGE CAPITAL PARTNERS GP |
5.3% |
view |
S |
2017-01-26 16:17:47.0 |
OvaScience |
OVAS |
JANUS CAPITAL MANAGEMENT LLC |
6.1% |
view |
B |
2016-02-16 10:55:08.0 |
OvaScience |
OVAS |
ADAGE CAPITAL PARTNERS GP LLC |
7.66% |
view |
S |
2016-02-16 06:43:53.0 |
OvaScience |
OVAS |
Arrowpoint Asset Management |
9.1% |
view |
B |
2015-03-10 17:00:45.0 |
OvaScience |
OVAS |
JANUS CAPITAL MANAGEMENT LLC |
11.6% |
view |
B |
2014-09-19 16:47:45.0 |
OvaScience |
OVAS |
ADAGE CAPITAL PARTNERS GP LLC |
5.56% |
view |
S |
2014-02-05 18:05:16.0 |
OvaScience |
OVSC |
General Catalyst Group V LP |
n/a |
view |
S |
2013-03-21 17:29:25.0 |
OvaScience |
OVSC |
General Catalyst Group V LP |
6.0% |
view |